Address: 11A Jalan P/1, Kawasan Perindustrian Bangi, Bandar Baru Bangi, 43650, Malaysia
Tel: 60 03 8925 7880
Web: http://www.pharmaniaga.com:8080/pharmaweb/mainindex.html
Pharmaniaga Berhad provides integrated healthcare solutions primarily in Malaysia. The company engages in manufacturing generic pharmaceuticals, and providing logistics and distribution, sales and marketing, medical products and services, hospital equipping and planning, turnkey contract management, and information technology solutions. It also engages in the research and development, and trade of generic pharmaceutical products; warehousing and distribution of pharmaceutical and medical products; and hospital equipment trading, as well as providing clinical laboratory testing and other laboratory related services. In addition, Pharmaniaga engages in the sale and distribution of portable medical devices, and distribution and trading of pharmaceuticals product, food supplements, and diagnostics product.
The company was founded in 1994 and is based in Shah Alam, Malaysia. It is the largest integrated local healthcare company in Malaysia. We are a public listed company on the main market of the Bursa Malaysia Securities Berhad with paid up capital of RM100 million.
Manufacturing of generic pharmaceuticals, logistics and distribution, sales and marketing, supply of medical products & services and hospital equipping
In the same week that you announced a rise in your Q3 profits your Managing Director resigned. How have you managed to achieve this increase in profits despite management uncertainties…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a distinguishing factor and this is why they are…
Novo Nordisk Malaysia’s general manager shares the ongoing fight to cure diabetes and talks about the necessity to raise awareness, with for instance their current MoU with the ministry of…
Malaysia Healthcare Travel Council’s CEO is proud of her country’s healthcare system and their efforts at attracting medical tourists from all over the world, with the support of the healthcare…
Mundipharma Malaysia’s country manager discusses his company’s aim to become a reference in Malaysia for pain management, on the back of the tremendous 48 percent growth of the business last year. …
Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to…
MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high quality doctors and strong government support. However,…
IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s general manager introduces this landmark and also…
Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing originators. Although Aspen is a renowned generic player, market dynamics…
MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time where most have decided to invest and base their…
See our Cookie Privacy Policy Here
